Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0001171843-16-008526

Options or other derivatives

  • VP, Clinical Development acquired 20,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

GOLDBERG Y. PAUL · VP, Clinical Development

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2016-03-11 Grant or award : show line 1 in the form Stock Option (Right to Buy) +20,000 $7.49 2026-03-10 20,000 20,000 D
Loading xslF345X03/formfour.xml…